Cardiac involvement in adults with m.3243A>G MELAS gene mutation

被引:51
|
作者
Vydt, Tom C. G.
de Coo, Ren F. M.
Soliman, Osama I. I.
ten Cate, Folkert J.
van Geuns, Robert-Jan M.
Vletter, Wim B.
Schoonderwoerd, Kees
van den Bosch, Bianca J. C.
Smeets, Hubert J. M.
Geleijnse, Marcel L. [1 ]
机构
[1] Erasmus MC, Dept Cardiol, Thoraxctr, Rotterdam, Netherlands
[2] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands
[4] Univ Maastricht, Dept Genet & Cell Biol, Res Inst GROW, Maastricht, Netherlands
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 99卷 / 02期
关键词
D O I
10.1016/j.amjcard.2006.07.089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac data in adults with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS syndrome) or asymptomatic gene carriers with the mitochondrial deoxyribonucleic acid adenine-to-guanine point mutation at nucleotide pair 3243 are scarce. Twelve subjects (mean-age 35 +/- 13 years), 8 with MELAS syndrome (patients) and 4 asymptomatic gene carriers (carriers), were enrolled in the study. Each subject underwent electrocardiography, exercise testing, Holter monitoring, echocardiography, and genetic and biochemical analysis for respiratory chain enzyme activity (complex I rest activity) in skeletal muscle. On electrocardiography and Hotter monitoring, none of the subjects had evidence of preexcitation, cardiac arrhythmias, or conduction abnormalities. Patients had significantly lower (42 +/- 17% from normal vs 103 +/- 14%, p < 0.02) exercise tolerance. All but 1 of the patients and none of the gene carriers had ragged red fibers on muscle biopsy. The mean percentage of gene mutation in skeletal muscle tended to be higher in patients (53 +/- 19%, range 19% to 73%) compared with carriers (33 +/- 20%, range 15% to 62%). Mean complex I rest activity in patients (36 +/- 18%, range 10% to 58%) was significantly (p < 0.01) lower compared with carriers (120 +/- 60%, range 72% to 205%). Left ventricular (LV) abnormalities were confined to patients with MELAS syndrome. Two patients had LV hypertrophy, 5 had LV systolic abnormalities, and 5 had LV diastolic dysfunction. Apart from 1 patient with an isolated LV diastolic abnormality, all patients with LV abnormalities had ragged red fibers. Patients with abnormal systolic LV function had a trend toward a higher percentage of mutated skeletal muscle (59.7 +/- 10.7% vs 35.8 +/- 21.3%, p < 0.10) and significantly lower complex I rest activity (26.7 +/- 14.0% vs 97.8% +/- 57.9, p < 0.01). In conclusion, none of the MELAS gene carriers had cardiac abnormalities, whereas most patients with the MELAS phenotype, particularly those with ragged red fibers, had LV involvement. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [21] Fear of disease progression in carriers of the m.3243A&gt;G mutation
    Custers, Jose A. E.
    de Laat, Paul
    Koene, Saskia
    Smeitink, Jan
    Janssen, Mirian C. H.
    Verhaak, Christianne
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [22] Diabetes is a risk factor for hypertension in adults with the m.3243A&gt;G mitochondrial DNA mutation
    Nesbitt, V.
    Bates, M. G. D.
    Turnbull, D. M.
    McFarland, R.
    NEUROMUSCULAR DISORDERS, 2011, 21 : S20 - S21
  • [23] Mitochondrial m.3243A&gt;G mutation and carotid artery dissection
    Mancuso, Michelangelo
    Montano, Vincenzo
    Orsucc, Daniele
    Peverelli, Lorenzo
    Caputi, Luigi
    Gambaro, Paola
    Siciliano, Gabriele
    Lamperti, Costanza
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 9 : 12 - 14
  • [24] ARCUS Gene Editing to Eliminate MELAS-Associated m.3243A&gt;G Mutant Mitochondrial DNA
    Shoop, Wendy
    Gorsuch, Cassandra
    Sevigny, Emma
    Bacman, Sandra
    Lape, Janel
    Smith, Jeff
    Jantz, Derek
    Moraes, Carlos
    MOLECULAR THERAPY, 2022, 30 (04) : 266 - 266
  • [25] Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A&gt;G melas mutation
    Moriarty, K. T.
    McFarland, R.
    Whittaker, R.
    Burch, J.
    Turnbull, H. E.
    Taylor, R. W.
    Turnbull, D. M.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 28 (03) : 349 - 349
  • [26] The heart in m.3243A&gt;G carriers
    Finsterer, J.
    Zarrouk-Mahjoub, S.
    HERZ, 2020, 45 (04) : 356 - 361
  • [27] High risk of severe cardiac adverse events in patients with mitochondrial m.3243A&gt;G mutation
    Malfatti, Edoardo
    Laforet, Pascal
    Jardel, Claude
    Stojkovic, Tanya
    Behin, Anthony
    Eymard, Bruno
    Lombes, Anne
    Benmalek, Amria
    Becane, Henri-Marc
    Berber, Nawal
    Meune, Christophe
    Duboc, Denis
    Wahbi, Karim
    NEUROLOGY, 2013, 80 (01) : 100 - 105
  • [28] High risk of severe cardiac adverse events in patients with mitochondrial m.3243A&gt;G mutation
    Duboc, D.
    Wahbi, K.
    Laforet, P.
    Varenne, O.
    Weber, S.
    Stojkovic, T.
    Behin, A.
    Eymard, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S182 - S182
  • [29] OPHTHALMOLOGICAL INVOLVEMENT IN M.3243A&gt;G-RELATED MITOCHONDRIAL DISEASE
    Devine, Helen
    Ng, Yi
    McFarland, Robert
    Gorman, Grainne
    Browning, Andrew
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [30] m.3243A&gt;G: Many faces of one single point mutation
    Lederer, Stephan R.
    Klopstock, Thomas
    Schiffl, Helmut
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (19-20) : 601 - 602